Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
38,512,859
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
23,321,104
-
Shares change
-
+2,729,498
-
Total reported value, excl. options
-
$32,404,117
-
Value change
-
+$3,831,682
-
Number of buys
-
18
-
Number of sells
-
14
-
Price
-
$1.39
Institutional Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) as of Q1 2023
As of 31 Mar 2023 Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) had 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 23,321,104 shares of stock of the company.
Largest 10 holders included Vivo Capital, LLC, CITADEL ADVISORS LLC, Sofinnova Investments, Inc., Pivotal bioVenture Partners Investment Advisor LLC, TANG CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, Nan Fung Group Holdings Ltd, Newtyn Management, LLC, Samsara BioCapital, LLC, and VANGUARD GROUP INC.
This table shows 48 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.